Unite as one to overcome difficulties and safeguard health! This Spring Festival, the severe outbreak of novel coronavirus-infected pneumonia in Wuhan City, Hubei Province, has attracted national attention, and the national epidemic of novel coronavirus-infected pneumonia has touched the hearts of people from all over the country. On the morning of January 30, Zhejiang Benefit Pharmaceutical Co., Ltd., through the Lishui Red Cross Society, donated influenza and pneumonia prevention traditional Chinese medicine formula granules to the Lishui Red Cross Society. The total value of the drugs is 1.13 million yuan, which will be distributed to the staff fighting on the front line of epidemic prevention in Lishui City for the fight against COVID-19, helping the society to win the battle of epidemic prevention and control. Ms. Wu Liwei, Executive Director of the company, attended the charity donation ceremony on behalf of the company.

The epidemic is an order, and prevention and control is a responsibility. As a pharmaceutical production enterprise, Benefit has the obligation to assume its due social responsibility and make a modest contribution. Since the outbreak of novel coronavirus-infected pneumonia, Benefit has established a leading and working group to respond to the epidemic. Chairman Wu Lihua serves as the leader of the leading group, has organized and held emergency meetings on epidemic prevention and control for many times, fully deployed the production of epidemic prevention and control drugs, established a reporting mechanism for employees' health care, and actively done a good job in epidemic prevention.

To ensure that the donated drugs are delivered to the front line of the fight against the epidemic in a timely manner, the company worked together, raced against time, completed the deployment and adjustment of all drugs within 48 hours. Starting from January 30, Ms. Wu Liwei, Executive Director, led a team to distribute the preventive drugs to various front-line work stations.